Supernus Pharmaceuticals Inc (SUPN)
SG&A Expenses
$560.88M
TTM · Period ending: · USD
SUPN SG&A Expenses
Latest reported$560.88Mperiod ending
Latest reported$560.88Mperiod ending
SUPN TTM SG&A Expenses ($7.93M → $560.88M)
TTM SG&A Expenses
High-resolution chart · PNG
SUPN sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 560,878,000 | |
| 520,792,000 | |
| 485,563,000 | |
| 442,582,000 | |
| 332,657,000 | |
| 325,010,000 | |
| 321,582,000 | |
| 323,455,000 | |
| 336,402,000 | |
| 337,280,000 | |
| 336,361,000 | |
| 329,051,000 | |
| 358,665,000 | |
| 372,359,000 | |
| 377,221,000 | |
| 404,984,000 | |
| 364,702,000 | |
| 333,761,000 | |
| 304,759,000 | |
| 259,324,000 | |
| 241,752,000 | |
| 220,320,000 | |
| 200,477,000 | |
| 179,902,000 | |
| 164,785,000 | |
| 156,459,000 | |
| 155,813,000 | |
| 162,138,000 | |
| 163,687,000 | |
| 164,007,000 | |
| 159,888,000 | |
| 151,602,000 | |
| 151,535,000 | |
| 146,516,000 | |
| 137,905,000 | |
| 133,196,000 | |
| 118,046,000 | |
| 109,089,000 | |
| 106,011,000 | |
| 100,522,000 | |
| 97,747,000 | |
| 94,962,000 | |
| 89,204,000 | |
| 83,656,000 | |
| 78,099,000 | |
| 74,344,000 | |
| 72,469,000 | |
| 69,674,000 | |
| 66,951,000 | |
| 59,584,000 | |
| 55,590,000 | |
| 49,051,000 | |
| 38,506,000 | |
| 30,937,000 | |
| 20,132,000 | |
| 14,233,000 | |
| 11,659,000 | |
| 8,909,000 | |
| 7,928,000 | |
| 6,834,232 | |
| 6,479,693 |